Insider · CIK 0001201254
Earl M Collier Jr
Files at CAPR (CAPRICOR THERAPEUTICS, INC.). First filing Oct 12, 2023, latest Oct 12, 2023.
In brief
Earl M Collier Jr files SEC Form 4 as director at CAPR (CAPRICOR THERAPEUTICS, INC.). Since Oct 12, 2023, Earl M Collier Jr has reported 1 open-market buy worth $28k and 0 open-market sells worth $0, the latest filed on Oct 12, 2023.
A track record needs three past buys with six months of prices behind them; Earl M Collier Jr has 0, so none is measured yet.
The newest scored trade: bought $28k of CAPR on Oct 10, 2023, filed Oct 12, 2023, scored 56 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CAPR: CAPRICOR THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 56Moderate | CAPRICOR THERAPEUTICS, INC. | $28k 10,000 shares | +59% | +3% from low-64% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock | +750 | $1.39 | $1,043 | 57,606 | Feb 28, 2025 |
| Feb 27, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -750 | $0.00 | $0 | 0 | Feb 28, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +11,940 | $0.00 | $0 | 11,940 | Jan 6, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +3,240 | $0.00 | $0 | 3,240 | Jan 6, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +5,750 | $0.00 | $0 | 5,750 | Jan 6, 2025 |
| Jan 2, 2024 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +29,250 | $0.00 | $0 | 29,250 | Jan 4, 2024 |
| Jan 2, 2024 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +8,030 | $0.00 | $0 | 8,030 | Jan 4, 2024 |
| Jan 2, 2024 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +14,280 | $0.00 | $0 | 14,280 | Jan 4, 2024 |
| Oct 10, 2023 | CAPR CAPRICOR THERAPEUTICS, INC. | POpen-market purchase Common Stock | +10,000 | $2.83 | $28k | 26,856 | Oct 12, 2023 |
Questions about Earl M Collier Jr
Answered from the filings on this page, as of the latest one.
Is Earl M Collier Jr buying or selling?
Not in the last 12 months. Earl M Collier Jr's latest open-market trade on SEC Form 4 was bought $28k of CAPR on Oct 10, 2023.
How did Earl M Collier Jr's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Earl M Collier Jr has 0.
Where does Earl M Collier Jr file Form 4?
Earl M Collier Jr has filed Form 4 at CAPR (CAPRICOR THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.